Papers
19
Total Citations
820
H-Index
14
About
Carlos Galvani is a pioneering surgical innovator whose career has been defined by his groundbreaking contributions to robotic-assisted minimally invasive surgery, spanning esophageal disease, transplantation, and pancreatic surgery. His most influential work centers on the application of robotic technology to complex abdominal procedures, fundamentally reshaping how surgeons approach technically demanding operations. Galvani's landmark 2005 multicenter study comparing robotic-assisted versus laparoscopic Heller myotomy for esophageal achalasia — now with 176 citations — established critical evidence supporting robotic platforms in foregut surgery. His subsequent investigations into robotically assisted transhiatal esophagectomy (115 citations) and robotic donor nephrectomy further demonstrated that robotic assistance could enhance safety, reduce learning curves, and expand surgical feasibility regardless of anatomical complexity, including cases involving vascular anomalies. Perhaps most remarkably, Galvani pioneered fully robotic total pancreatectomy combined with autologous islet transplantation for chronic pancreatitis patients — an extraordinary technical achievement aimed at eliminating surgically induced diabetes. This series, cited 56 times, represents a fusion of surgical innovation and transplant medicine rarely seen in the field. Across more than a decade of contributions, Galvani's work has collectively amassed hundreds of citations, cementing his reputation as a transformative leader in robotic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotically assisted laparoscopic transhiatal esophagectomy115 citations · 2007
- 3
- 4Laparoscopic Heller myotomy for achalasia facilitated by robotic assistance72 citations · 2006
- 5
- 6
- 7
- 8
- 9
- 10